Neuropeptide-induced inhibition of IL-16 release from eosinophils

NeuroImmunoModulation

Volumn 10, Issue 4, 2002, Pages 217-223

  Dunzendorfer, Stefan ^a   Feistritzer, Clemens ^a   Enrich, Barbara ^a   Wiedermann, Christian J ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Eosinophils; Interleukin 16; Lymphocyte chemotaxis; Neuroimmunology; Peripheral neuropeptides

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOMODULATING AGENT; INTERLEUKIN 16; INTERLEUKIN 5; NEUROPEPTIDE; SECRETONEURIN; SUBSTANCE P; VASOACTIVE INTESTINAL POLYPEPTIDE;

ARTICLE; CELL SECRETION; CELL SELECTION; CELL STIMULATION; CHEMOTAXIS; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; HUMAN; HUMAN CELL; IMMUNOMODULATION; LYMPHOCYTE; PRIORITY JOURNAL; SUPERNATANT;

ADJUVANTS, IMMUNOLOGIC; ANTI-INFLAMMATORY AGENTS; CALCITONIN GENE-RELATED PEPTIDE; CELLS, CULTURED; CHEMOTAXIS, LEUKOCYTE; DOWN-REGULATION; EOSINOPHILS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-16; INTERLEUKIN-5; NEUROIMMUNOMODULATION; NEUROPEPTIDES; SECRETOGRANIN II; SUBSTANCE P; UP-REGULATION; VASOACTIVE INTESTINAL PEPTIDE;

EID: 0036992917     PISSN: 10217401     EISSN: None     Source Type: Journal    
DOI: 10.1159/000068324     Document Type: Article

References (30)

1. Giembycz MA, Lindsay MA: Pharmacology of the eosinophil. Pharmacol Rev 1999;51:213-340.
2. Kato M, Kephart GM, Talley NJ, Wagner JM, Sarr MG, Bonno M, McGovern TW, Gleich GJ: Eosinophil infiltration and degranulation in normal human tissue. Anat Rec 1998;252:418-425.
3. Rytomaa T: Organ distribution and histochemical properties of eosinophil granulocytes in the rat. Acta Pathol Microbiol Scand 1960;50(suppl 140):12-18.
4. Spry CJF: The natural history of eosinohils; in Smith H, Cook R (eds): Immunopharmacology of Eosinophils. London, Academic Press, 1993 pp 1-9.
5. Gonzalo JA, Lloyd CM, Wen D, Albar JP, Wells TN, Proudfoot A, Martinez-A C, Dorf M, Bjerke T, Coyle AJ, Gutierrez-Ramos JC: The coordinated action of CC chemokines in the lung orchestrates allergic inflammation and airway hyperresponsiveness J Exp Med 1998;188:157-167.
6. Gavett SH, O'Hearn DJ, Li X, Huang SK, Finkelman FD, Wills-Karp M: Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice. J Exp Med 1995;182:1527-1536.
7. Grewe M, Czech W, Morita A, Werfel T, Klammer M, Kapp A, Ruzicka T, Schopf E, Krutmann J: Human eosinophils produce biologically active IL-12: Implications for control of T cell responses. J Immunol 1998;161:415-420.
8. Laberge S, Pinssoneault S, Ernst P, Olivenstein R, Ghaffar O, Center DM, Hamaid Q: Phenotype of IL-16-producing cells in bronchial mucosa: Evidence for the human eosinophil and mast cell as cellular sources of IL-16 in asthma. Int Arch Allergy Immunol 1999;119:120-125.
9. Hessel EM, Cruikshank WW, Van Ark I, De Bie JJ, Van Esch B, Hofman G, Nijkamp FP, Center DM, Van Oosterhout AJ: Involvement of IL-16 in the induction of the airway hyperresponsiveness and up-regulation of IgE in a murine model of allergic asthma. J Immunol 1998;160:2998-3005.
10. Mashikian MV, Tarpy RE, Saukkonen JJ, Lim KG, Fine GD, Cruikshank WW, Center DM: Identification of IL-16 as the lymphocyte chemotactic activity in the bronchoalveolar lavage fluid of histamine-challenged asthmatic patients. J Allergy Clin Immunol 1998;101:786-792.
11. Kaser A, Dunzendorfer S, Offner FA, Ryan T, Schwabegger A, Cruikshank WW, Wiedermann CJ, Tilg H: A role for IL-16 in the crosstalk between dendritic cells and T-cells. J Immunol 1999;163:3232-3238.
12. Hökfelt T, Kellerth JO, Nilsson G, Pernow B: Substance P localization in the central nervous system and some primary sensory neurons. Science 1987;190:889-890.
13. Payan DG: Neuropeptides and inflammation: The role of substance P. Annu Rev Med 1989;40:341-352.
14. Pernow B: Substance P. Pharmacol Rev 1983;35:85-141.
15. Goetzl EJ, Adelmann DC, Sreedharan SP: Neuroimmunology. Adv Immunol 1990;8:161-190.
16. Dunzendorfer S, Schratzberger P, Reinisch N, Kahler CM, Wiedermann CJ: Secretoneurin, a novel neuropeptide, is a potent chemoattractant for human eosinophils. Blood 1998;91:1527-1532.
17. Schratzberger P, Reinisch N, Prodinger WM, Kahler CM, Sitte BA, Bellmann R, Fischer-Colbrie R, Winkler H, Wiedermann CJ: Different chemotactic activities of sensory neuropeptides for human peripheral blood mononuclear cells. J Immunol 1997;158:3895-3901.
18. Voice JK, Dorsam G, Lee H, Kong Y, Goetzl E: Allergic diathesis in transgenic mice with constitutive T cell expression of inducible vasoactive intestinal peptide receptor. FASEB J 2001;15:2489-2496.
19. Costello RW, Schofield BH, Kephart GM, Gleich GJ, Jacoby DB, Fryer AD: Localization of eosinophils to airway nerves and effect on neuronal M2 muscarinic receptor function. Am J Physiol 1997;273:L93-103.
20. Dunzendorfer S, Woell E, Frade JMR, Mellado M, Martinez-A. C, Wiedermann CJ: Functional expresssion of CCR2 by normal human eo-sinophils. J Allerg Clin Immunol 2001;108:581-587.
21. Han ZQ, Coppock HA, Smith DM, van Noordon S, Makgoba MW, Nicholl CG, Legon S: The interaction of CGRP and adrenomodullin with a receptor expressed in the rat pulmonary vascular endothelium. J Mol Endocrinol 1997;18:267-272.
22. Tai PC, Sun L, Spry CJ: Effects of IL-5, granulocyte/macrophage colony-stimulating factor (GM-CSF) and IL-3 on the survival of human blood eosinophils in vitro. Clin Exp Immunol 1991;85:312-316.
23. Barnes PJ, Chung KF, Page CP: Inflammatory mediators of asthma. An update. Am Soc Pharmac Exp Therap 1988;50:515-598.
24. Bates ME, Berties PJ, Busse WW: IL-5 activates a 45-kilodalton mitogen-activated protein (MAP) kinase and Jak-2 tyrosine kinase in human eosinophils. J Immunol 1996;156:711-718.
25. Hiraguri M, Miike S, Sano H, Kurasawa K, Saito Y, Iwamoto I: Granulocyte-macrophage colony-stimulating factor and IL-5 activate mitogen-activated protein kinase through Jak2 kinase and phosphatidylinositol 3-kinase in human eosinophils. J Allergy Clin Immunol 1997;100:45-51.
26. Pazdrak K, Olszewska-Pazdrak B, Stafford S, Garofalo RP, Alam R: Lyn, Jak2, and Raf-1 kinases are critical for the antiapoptotic effect of interleukin 5, whereas only Raf-1 kinase is essential for eosinophil activation and degranu-lation. J Exp Med 1998;188:421-429.
27. Bracke M, Dubois GR, Bolt K, Bruijnzeel PL, Vaerman JP, Lammers JW Koenderman L: Differential effects of the T helper cell type 2-derived cytokines IL-4 and IL-5 on ligand binding to IgG and IgA receptors expressed by human eosinophils. J Immunol 1997;159:1459-1465.
28. Bracke M, Nijhuis J, Lammers JW, Coffer PJ, Koenderman L: A critical role for PI-kinase in cytokine-induced Fc-receptor activation. Blood 2000;95:2037-2043.
29. Bermann JS, Cruikshank WW, Center DM, Theodore AC, Beer DJ: Chemoattractant lymphokines specific for the helper/inducer T-lymphocyte subset. Cell Immunol 1985;95:105-112.
30. Dunzendorfer S, Wiedermann CJ: Neuropeptide-induced chemotaxis of eosinophils in pulmonary diseases. Ann Med 2000;32:429-439.